Novartis, which already has experience with RNA interference therapies, is now turning to this modality as a potential way to treat Parkinson’s disease. The pharmaceutical giant is licensing rights to an Arrowhead Pharmaceuticals RNAi therapy designed to inhibit production of alpha synuclein, a protein associated with Parkinson’s progression. The post Novartis Tries Again in Parkinson’s,…
This analysis examines the share of inpatient hospital days that are covered by Medicaid nationally and by state at a time when Congress is considering potential cuts to the program. It finds that Medicaid covered at least one in five inpatient hospital days in 48 states and the District of Columbia in 2023.
Hinge Health is the first musculoskeletal care provider to be added to Amazon’s Health Condition Programs. The post Hinge Health, Amazon Health Services Team Up to Broaden Access to MSK Care appeared first on MedCity News.
Navina closed a $55 million Series C funding round led by Goldman Sachs. The company, based in Israel and New York, uses AI to help primary care physicians thrive in value-based care models. The post Navina Snags $55M for Its Value-Based Care AI Copilot appeared first on MedCity News.
In the 2024 election, seven out of 10 states passed ballot measures protecting abortion rights. But the effects won’t be seen immediately, experts say. The post 7 States Passed Abortion Rights Ballot Measures. But Changes Won’t be Like a “Light Switch,” Experts Say appeared first on MedCity News.
A planned interim clinical trial analysis found Praxis Precision Medicines drug ulixacaltamide was unlikely to succeed as a treatment for essential tremor. But Praxis is continuing two late-stage tests of the drug; data are expected in the third quarter of 2025. The post Praxis Presses Forward in Essential Tremor Despite Futility Finding From Trial Observers…
Providers need a revenue cycle management platform that is more affordable and accurate, said Jeremy Dekinsky, CEO of Smarter Technologies, during MedCity News’ INVEST conference. New Mountain Capital formed Smarter Technologies this week by combining three separate platforms it had already acquired. The post How a New PE-Backed RCM Company Plans to Fix the ‘Transactional…
Sumana Reddy, a primary care physician, struggles on thin financial margins to run Acacia Family Medical Group, the small independent practice she founded 27 years ago in Salinas, a predominantly Latino city in an agricultural valley often called “the salad bowl of the world.” Reddy can’t match the salaries offered by larger health systems —…
The Washington Post reports on a meeting between President-elect Trump, Robert F. Kennedy, Jr. and a number of CEOs of pharmaceutical firms. When the topic turned to vaccines, the discussion was not about banning the products, the three people said. Kennedy spoke about the need for better study of the vaccine dosing schedule for newborns…
Kailera Therapeutics licensed its portfolio of metabolic disorder drugs from Hengrui. The most advanced program has results from a Phase 2 test in China suggesting it could be competitive with other medications that target the GLP-1 and GIP receptors to trigger weight loss. The post Metabolic Meds Biotech Kailera Launches With $400M for Next-Generation Weight-Loss…